Gene Therapy For Muscular Dystrophy Linked To Patient Death
A patient has died following treatment with Sarepta’s gene therapy Elevidys, which treats muscular dystrophy. The 27% drop in the company’s shares comes after the patient suffered acute liver injury, a known side effect of the therapy. Although the severity of this case had not been seen before, Sarepta says it plans to update the … Read more